Narrative review / 2008
Lutein and zeaxanthin are linked to lower cataract risk in postmenopausal women and improved AMD features in patients.
This review discusses phytochemicals and age-related eye conditions such as cataracts, glaucoma, and AMD. Observational and clinical trials support the safety of higher intakes of lutein and zeaxanthin and their association with reduced cataract risk in healthy postmenopausal women and improved clinical features of AMD in patients. Other phytochemicals such as green tea catechins, anthocyanins, resveratrol, and Ginkgo biloba also show promise for reducing ocular oxidative stress.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Healthy postmenopausal women and patients with AMD
- What was measured
- Risk of cataracts and clinical features of age-related macular degeneration
THE PAPER
Phytochemicals and age-related eye diseases.
Rhone M, Basu A. Nutr Rev, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.